Abstract
Abstract
Background
Homeostatic regulation of cardiomyocytes is indispensable in maintaining the normal physiological activity of cardiac tissue. Cardiotoxicity induced by drugs may lead to cardiac abnormalities such as arrhythmia, myocardial infarction and myocardial hypertrophy. Moreover, drug-induced cardiotoxicity confines the additional use of the implicated drugs. Several studies have reported that consumption of phytochemicals on regular intervals shall protect humans against numerous diseases such as diabetes, cardiovascular disease, inflammatory diseases and cancer.
Main body
Ferulic acid (FA) is a plant derived polyphenol abundantly found in vegetables, fruits and grains. FA is widely known for its antioxidant, anti-inflammatory, anticancer, nephroprotective and hepatoprotective effects. FA has been well documented for its cardioprotective activity against various drugs and toxic agents as well. However, the cardioprotective action of FA have remained a challenge with regard to understanding its mechanism in health and diseases.
Conclusion
The main purpose of this review is to explore the cardioprotective mechanisms of FA against several drugs and chemicals to recommend further studies to investigate the potential protective effect of FA.
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science,Agricultural and Biological Sciences (miscellaneous),Medicine (miscellaneous)
Reference69 articles.
1. Vater LB, Lefebvre B, Turk A, Clasen SC (2022) Fluoropyrimidine cardiotoxicity: Incidence, outcomes, and safety of rechallenge. Curr Oncol Rep. https://doi.org/10.1007/s11912-022-01256-6
2. Leong Bin Abdullah MFI, Singh D (2021) The adverse cardiovascular effects and cardiotoxicity of Kratom (Mitragyna speciosa Korth.): a comprehensive review. Front Pharmacol 27;12:726003.
3. Bhagat A, Kleinerman ES (2020) Anthracycline-Induced cardiotoxicity: causes, mechanisms, and prevention. Adv Exp Med Biol 1257:181–192
4. Pistillucci G, Ciorra AA, Sciacca V, Raponi M, Rossi R, Veltri E (2015) Troponina I e Peptide Natriuretico Cerebrale (BNP) come biomarcatori predittivi di cardiotossicità nelle pazienti affette da carcinoma della mammella in terapia adiuvante con antracicline e trastuzumab [Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab]. Clin Ter 166(1):e67–71. Italian.
5. Patel VG, Cornell RF (2019) Cardiovascular complications associated with multiple myeloma therapies: incidence, pathophysiology, and management. Curr Oncol Rep 21(4):29
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献